Index»
an
»
blocker
»
considers
»
fat
»
fda
»
of
»
otc
»
the
»
update
»
version
»
xenical
»
Update FDA Considers an OTC Version of the Fat blocker Xenical
The FDA usually follows the recommendation of its advisory committees. Full FDA approval could be months away.
* If you have diabetes, its advisable to consult with your doctor before taking non-prescription orlistat (Alli). Its use may necessitate changes to diabetes medications.
________
GlaxoSmithKlines Press Release:
FDA Joint Advisory Committee Recommends Approval of Orlistat 60 MG Capsules for Over-the-counter Use
News summaries:
Diet Pill Gets Closer to Store Shelves
FDA Panel Recommends OTC Weight-Loss Pill
Update FDA Considers an OTC Version of the Fat blocker Xenical
Sunday, January 19, 2014
The FDA advisory committee voted 11 to 3 today to recommend the OTC version of orlistat* for final FDA approval.The FDA usually follows the recommendation of its advisory committees. Full FDA approval could be months away.
* If you have diabetes, its advisable to consult with your doctor before taking non-prescription orlistat (Alli). Its use may necessitate changes to diabetes medications.
GlaxoSmithKlines Press Release:
FDA Joint Advisory Committee Recommends Approval of Orlistat 60 MG Capsules for Over-the-counter Use
News summaries:
Diet Pill Gets Closer to Store Shelves
FDA Panel Recommends OTC Weight-Loss Pill
Subscribe to:
Post Comments (Atom)
.jpg)
No comments:
Post a Comment